Abionic is a company headquartered in Switzerland. Brouky records 1 investor associated with the company.
Abionic is a Swiss medical diagnostics company that develops nanotechnology-based point-of-care immunoassay systems (notably the abioSCOPE) and related rapid in vitro diagnostic tests.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.